ANTIPHOSPHOLIPID SYNDROME
Clinical trials for ANTIPHOSPHOLIPID SYNDROME explained in plain language.
Never miss a new study
Get alerted when new ANTIPHOSPHOLIPID SYNDROME trials appear
Sign up with your email to follow new studies for ANTIPHOSPHOLIPID SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Withdrawn trial: experimental drug aimed to stop dangerous blood clots
Disease control TerminatedThis study aimed to test whether adding crovalimab to standard blood thinners could better prevent dangerous blood clots in people with antiphospholipid syndrome. The trial was designed for adults with a history of blood clots who were already taking blood-thinning medication. Ho…
Matched conditions: ANTIPHOSPHOLIPID SYNDROME
Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Mar 09, 2026 14:25 UTC
-
Tracking High-Risk pregnancies to unlock better care for women with rare diseases
Knowledge-focused TerminatedThis study aimed to gather information about pregnancy in women with rare autoimmune diseases like lupus and rheumatoid arthritis. Researchers planned to follow these pregnancies to understand complications and how medications affect both mother and baby. The goal was to use this…
Matched conditions: ANTIPHOSPHOLIPID SYNDROME
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:02 UTC